Furthermore, it was previously shown that the abolishment of interferon regulatory factor 3 (IRF3) or IFN-α receptor 1 ameliorated the AGS symptoms in trex1-deficient mice (Stetson et al., 2008). This evidence concerns the gene IRF3 and Aicardi-Goutieres syndrome.